Moderna, INC DEF 14A proxy statements

Moderna, Inc. has filed its definitive proxy statement with the SEC, an administrative step for shareholder meetings.

Moderna is seeking shareholder approval for a one-time stock option exchange program designed to retain non-Executive Committee employees by addressing significantly underwater stock options.

Moderna Inc. has filed definitive additional proxy soliciting materials with the Securities and Exchange Commission.

Moderna's 2025 proxy statement outlines key proposals for the annual shareholder meeting, including the election of directors, an advisory vote on executive compensation, and the ratification of the company's independent auditor.

Moderna, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to its upcoming shareholder meeting.

Moderna's proxy statement outlines proposals for the upcoming annual meeting, including director elections, executive compensation, and amendments to the company's certificate of incorporation.